Nuritas secures $42 million in Series C funding

News
Article

The funding round included major investments from McWin Capital Partners and M&G Investments.

Photo © iStockphoto.com/pavlen

Photo © iStockphoto.com/pavlen

Nuritas, a company specializing in AI-powered peptide discovery, has announced the successful close of an oversubscribed $42 million Series C funding round. The round was led by M&G Investments, on behalf of its Catalyst strategy. The private equity firm and venture capital firm, McWin Capital Partners, joined the funding round as a key investor, which will further Nuritas’ foundation for global expansion. McWin Capital Partners focuses on high-growth companies in the food ecosystem while the M&G Catalyst Fund is a purpose-led initiative that supports transformative businesses that address global social and environmental challenges. According to a press release from McWin Capital Partners says that together with M&G’s Catalyst Capital Fund, the firms aim to help Nuritas “scale sales, expand their product portfolio and grow their team to boost its commercial presence and establish itself as one of the leading companies in the clean nutrition and functional ingredients space.” Nuritas’ current investors, Grosvenor and ECBF, also participated in the funding round.

"McWin Capital Partners are the perfect partners to join us on this journey and help us continue to innovate and grow the business,” said Nora Khaldi, PhD, founder and CEO of Nuritas in a press release. “Their experience working in the food sector and with companies on the cutting edge of innovation will be a huge asset to our team and to the benefit of our customer network. We look forward to the partnership.”

As part of the funding round, Alex Seddon, head of impact and private equity at M&G Investments and Henry McGovern, co-founder of McWin Capital Partners, is joining the Nuritas Board of Directors. “We are proud to lead this round of investment into Nuritas, as they continue to leverage the AI-powered Magnifier platform to discover novel, functional ingredients that will provide broad-based preventative health benefits,” said Seddon, in a press release. “This investment reflects our commitment to supporting scalable solutions that deliver measurable impact. By partnering with Nuritas, we look forward to supporting their groundbreaking work, ultimately advancing sustainable, healthier outcomes for people and the planet.”

"We are thrilled to join Nuritas at this pivotal moment in their journey,” added Martin Davalos, partner and head of food tech at McWin Capital Partners. “Henry McGovern and I bring complementary expertise, and together with the Nuritas team, we are excited to help accelerate their growth. We are passionate about healthier, safer and more sustainable products and believe consumers worldwide should have the right to access these with ease - and Nuritas are at the forefront of developing technology and products to meet that need.”

Related Content
© 2025 MJH Life Sciences

All rights reserved.